United Kingdom · Responsive
Klas Therapeutics Ltd
Klas Therapeutics Ltd is a UK early-stage company with 2 public funding or programme announcements on record, most recently 1 Jun 2025.
Announcements
Innovate UK funding awarded
£412,546 · Collaborative R&D grant; “A collaborative approach to establish the metabolites and safety of KT-001, advancing the ”; Northern Ireland
Invest NI financial support offered
£7,213 · Invest NI offer: Entrepreneurship & Enterprise; Belfast; Northern Ireland
Is this your company?
Everything here comes from the public announcement or open dataset linked above. If something is wrong or out of date, or you would rather not be listed, email hello@capitalsignals.uk.
Not a recommendation
Support or selection by Innovate UK and Invest NI is not a sign that the company is a good investment. Most early-stage companies cannot be invested in by the public, and many fail.